CTLA4Ig/VISTAIg combination therapy selectively induces CD4 <sup>+</sup> T cell‐mediated immune tolerance by targeting the SOCS1 signaling pathway in porcine islet xenotransplantation-Reference-Cited by-同舟云学术

CTLA4Ig/VISTAIg combination therapy selectively induces CD4 ⁺ T cell‐mediated immune tolerance by targeting the SOCS1 signaling pathway in porcine islet xenotransplantation

Published:2022-03-17 Issue:2 Volume:166 Page:169-184
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Wang Dan¹²,Bai Xue¹³,Wang Bin⁴,Yi Qiying⁵,Yu Weihua⁶,Zhang Xinying¹³,Tian Ruoyuan¹³,Zhang Xiao¹³,Li Caihua¹³,Chen Yi¹³,Liu Yang¹³,Cheng Yao⁷,He Sirong¹³^ORCID

Affiliation:

1. Department of Immunology College of Basic Medicine Chongqing Medical University Chongqing China

2. Department of Respiratory and Critical Care Medicine The First Affiliated Hospital of Chongqing Medical University Chongqing China

3. Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology College of Basic Medicine Chongqing Medical University Chongqing China

4. Institute of Life Science Chongqing Medical University Chongqing China

5. Laboratory Animal Center Chongqing Medical University Chongqing China

6. Institutes of Neuroscience Chongqing Medical University Chongqing China

7. Department of Hepatobiliary Surgery The Second Affiliated Hospital of Chongqing Medical University Chongqing China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13463

Reference39 articles.

1. Xenotransplantation: current status and a perspective on the future